Antilithiatic activity of the aqueous extract of the roots of Tephrosia purpurea Linn

Pharmacognosy Magazine

Volumn 4, Issue 16 SUPPL., 2008, Pages

  Swathi, D ^a   Sujatha, D ^a   Bharathi, K ^a   Prasad, K V S R G ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

Antilithiatic activity; Calcium oxalate stones; Calculi producing diet; Foreign body implantation method; Magnesium ammonium phosphate stones; Tephrosia purpurea

Indexed keywords

CALCIUM; GENTAMICIN; MAGNESIUM; OXALIC ACID; PHOSPHATE; PLANT EXTRACT; TEPHROSIA PURPUREA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM EXCRETION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; MALE; NONHUMAN; PLANT ROOT; RAT; TEPHROSIA; TEPHROSIA PURPUREA; UROLITHIASIS;

EID: 74249085230     PISSN: 09731296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. B. Otnes. Quantitative observations on crystalline composition of urinary stones. Scan. J. Urol. Nephrol. 17: 185-190 (1983).
2. J.R. Asplin, M. Favus, F.L. Coe. Nephrolithiasis. In B.M. Brenner (6th Ed), Brenner and Rector's. Philadelphia: W.B. Saunders, (2000), pp 1774-1819.
3. P.C. Walsh, A.B. Retik, E.D. Vaughan. In- Campbell's Urology. Eds (7). Philadelphia: WB Saunders Co, (1997), pp 2661-2733.
4. B.L. Dietrich, R. Balschke, W. Schmandt. Results of 5305 stone analysis. A contribution to epidemiology of urinary stone disease. Scand. J. Urol and Nephrol. 24: 205-210 (1990).
5. C.W. Vermeulen, W.J. Grove, R. Goetz. The influence of urine volume upon calculi experimentally produced upon foreign bodies. J. Urol 64: 541-544 (1950).
6. K.R. Kirtikar, B.D. Basu. Indian medicinal plants. International book distributors, Dehradoon, (1975), pp 725.
7. J. Crossland. Lewis Pharmacology. Churchill Livingstone. New York, (1980), pp 137.
8. st Ed, (1972), pp 124.
9. Sanjaykumar, D. Sigmon, T. Miller, B. Carpenter, S. Khan, R. Malhotra, C. Schied, M. Menon. A new model of nephrolithiasis involving tubular dysfunction/injury. J. Urol. 146: 1384-9 (1991).
10. K. Lorentz. Improved determination of serum calcium with ortho cresolphthalein complexone. Clin. Chim. Acta 126: 327-333 (1982).
11. A. Hodgkinson, A. Williams. An improved colorimetric procedure for urinary oxalate. Clin. Chim. Acta. 36: 127-132 (1972).
12. J.D. Bauer. Clinical laboratory methods. B1 Publications Ltd. New Delhi: pp 511-512 (1990).
13. nd Ed. NewYork. Harper and Row, (1974a), pp 723-727.
14. C.W. Vermeulen, R. Goetz. Experimental urolithiasis VII. Role and genetic strain in determining chemical composition of stones. J. Urol. 72: 93-98 (1954).
15. nd Ed. NewYork. Harper and Row, (1974b), pp 1577.
16. th Ed. Philadelphia, WB Saunders and Co, (2002), pp 2661-2733.
17. Alberto trinchieri. Epidemiological trends in urolithiasis: Impact on our healthcare systems. J. Urol. Res. 34: 151-156 (2006).
18. K. Kevin, Frick, D.A. Bushinsky. Molecular mechanisms of primary hypercalciuria. Nephrology. 14: 1082-1095 (2003).
19. S.B. Chahwala, E.S. Harpur. Gentamicin- induced hypercalciuria in the rat. Acta . Pharmacol. Toxicol. 53: 358-362 (1983).
20. A.J.M. Christina, N.A. Haja Najumadeen, S. Vimal Kumar, N. Manikandan, G.C. Tobin, S. Venkataraman, N. Murugesh. Antilithiatic Effect of Melia azedarach on Ethylene Glycol-Induced Nephrolithiasis in Rats. Pharmaceutical Biology. 44(6): 480-485 (2006).
21. W.G. Robertson, M. Peacock. The course of idiopathic calcium disease: Hypercalciuria or Hyperoxaluria. Nephron 26: 105-110 (1980).
22. S. Moore, G. Gowland. The immunologic integrity of matrix substance A and its possible detection and quantification in urine. Br. J. Urol. 47: 489-494 (1975).
23. C.Y.C. Pak. Renal stone disease. Boston Martinus Nijhoff Publishing, (1987), pp 120-128.
24. K.V.S.R.G. Prasad, K. Bharathi, K.K. Srinivasan. Evaluation of Ammania baccifera Linn. For antiurolithiatic activity in albino rats. Ind. J. Expt. Biol. 32: 311-313 (1994).
25. R. Vargas. S, R.M. Perez. G, S. Perez. G, M.A. Zavala. S, C. Perz. G. Antiurolithiatic activity of Raphanus sativus extract on rats. J Ethnopharmacol. 68: 335-338(1999).
26. R.M. Perez. G, R. Vargas. S, S. Perez. G, M.A. Zavala. S, C. Perz. G. Antiurolithiatic activity of 7-hydroxy-2′,4′,5′- trimethoxyisoflavone and 7-hydroxy-4′-methoxy isoflavone from Eysenhardtia polystachya. Journal of Herbs, Spices and Medicinal Plants. 7(2): 27-34 (2000).
27. F. Grases, J.G. March, M. Ramis, A. Costa - Bauza. The influence of Zea mays on urinary risk factors for kidney stones in rats. Phytother Res 7: 146-149 (1993).
28. J.S. King Jr. Etiologic factors involved in urolithiasis . A review of recent research. J. Urol. 97: 583-591 (1967).